Abisror N, Mekinian A, Lavigne C et al (2013) Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review. Autoimmun Rev 12:1143–1149

Article  CAS  PubMed  Google Scholar 

Yun S, Sim E, Goh R, Park J, Han J (2016) Platelet activation: the mechanisms and potential biomarkers. Biomed Res Int 2016:1–5

Article  Google Scholar 

Iba T, Levy JH (2018) Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost 16:231–241

Article  CAS  PubMed  Google Scholar 

Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD (2019) The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med 39:345–357

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaushansky K (2005) The molecular mechanisms that control thrombopoiesis. J Clin Investig 115:3339–3347

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schrottmaier WC, Mussbacher M, Salzmann M, Assinger A (2020) Platelet-leukocyte interplay during vascular disease. Atherosclerosis 307:109–20

Article  CAS  PubMed  Google Scholar 

Pan L, Du J, Li T, Liao H (2017) Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu’s arteritis: a case-control study. BMJ Open 7:e14451

Article  Google Scholar 

Wang X, Dang A, Lv N, Cheng N, Cheng X (2017) Inflammation is associated with platelet coagulation function rather than enzymatic coagulation function in patients with Takayasu arteritis. Int Heart J 58:589–592

Article  CAS  PubMed  Google Scholar 

Chen R, Ma L, Lv P et al (2021) Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis. Arthritis Res Ther 23:63

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seringec Akkececi N, Yildirim Cetin G, Gogebakan H, Acipayam C (2019) The C-reactive protein/albumin ratio and complete blood count parameters as indicators of disease activity in patients with takayasu arteritis. Med Sci Monitor 25:1401–1409

Article  Google Scholar 

Arend WP, Michel BA, Bloch DA et al (1990) The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134

Article  CAS  PubMed  Google Scholar 

Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54:S155–S163

Article  PubMed  Google Scholar 

Gail Kerr MMS, Hallahan CWM, Joseph Giordano M et al (1994) Takayasu arteritis. Ann Intern Med 120:919–29

Article  Google Scholar 

Misra R, Danda D, Rajappa SM et al (2013) Development and initial validation of the Indi (ITAS2010). Rheumatology 52:1795–1801

Article  PubMed  Google Scholar 

Misra R, Misra D, Danda D, Lawrence A, Bacon P (2013) ITAS.a suggests persistent disease activity in Takayasu aorto-arteritis (TA) after induction therapy. La Presse Méd 42:729–30

Article  Google Scholar 

Hellmich B, Agueda A, Monti S et al (2019) 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 79:19–30

Article  PubMed  Google Scholar 

Jiang L, Li D, Yan F, Dai X, Li Y, Ma L (2012) Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging. Int J Cardiol 155:262–267

Article  PubMed  Google Scholar 

Watanabe T, Kishi Y, Numano F, Isobe M (2001) Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis. Thromb Res 104:77–83

Article  CAS  PubMed  Google Scholar 

El-Dairi MA, MLCM, Thomas J. Cummings MSSS (2015) Diagnostic algorithm for patients with suspected giant cell arteritis. J Neuro-Ophthalmol 35:246–53

Article  Google Scholar 

Oh LJ, Wong E, Andrici J, McCluskey P, Smith JEH, Gill AJ (2018) Full blood count as an ancillary test to support the diagnosis of giant cell arteritis. Intern Med J 48:408–413

Article  CAS  PubMed  Google Scholar 

Bornstein G, Barshack I, Koren-Morag N, Ben-Zvi I, Furie N, Grossman C (2018) Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis. Clin Rheumatol 37:2819–2824

Article  PubMed  Google Scholar 

Walvick MD, Walvick MP (2011) Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy. Ophthalmology 118:1201–1204

Article  PubMed  Google Scholar 

Zha Q, He Y, Lu Y, Lu A (2006) Relationship between platelet counts and cartilage erosion in 436 cases of rheumatoid arthritis. Clin Chim Acta 371:194–195

Article  CAS  PubMed  Google Scholar 

Maric LS, Knezovic I, Papic N et al (2015) Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience. Rheumatol Int 35:1053–1058

Article  PubMed  Google Scholar 

Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R (2018) Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease. Paediatr Int Child H 38:209–212

Google Scholar 

Elmas AT, Tabel Y (2016) Platelet counts in children with henoch-schonlein purpura-relationship to renal involvement. J Clin Lab Anal 30:71–74

Article  PubMed  Google Scholar 

Margraf A, Zarbock A (2019) Platelets in inflammation and resolution. J Immunol 203:2357–2367

Article  CAS  PubMed  Google Scholar 

Lupia E, Goffi A, Bosco O, Montrucchio G (2012) Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases. Mediat Inflamm 2012:1–12

Article  Google Scholar 

Ramirez GA, Manfredi AA, Maugeri N (2019) Misunderstandings between platelets and neutrophils build in chronic inflammation. Front Immunol 10:2491

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu O, Jia L, Liu X et al (2012) Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. PLoS ONE 7:e51707

Article  CAS  PubMed  PubMed Central  Google Scholar 

von Hundelshausen P, Schmitt MMN (2014) Platelets and their chemokines in atherosclerosis—clinical applications. Front Physiol 5:294

Google Scholar 

Hu H, Zhu L, Huang Z et al (2010) Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus. Thromb Haemost 104:1184

Article  CAS  PubMed  Google Scholar 

Li N (2013) CD4+ T cells in atherosclerosis: regulation by platelets. Thromb Haemost 109:980

Article  CAS  PubMed  Google Scholar 

Rossaint J, Margraf A, Zarbock A (2018) Role of platelets in leukocyte recruitment and resolution of inflammation. Front Immunol 9:2712

Article  PubMed  PubMed Central  Google Scholar 

Khandoga A, Hanschen M, Kessler JS, Krombach F (2006) CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 43:306–315

Article  CAS  PubMed  Google Scholar 

Bergmann CB, Hefele F, Unger M et al (2016) Platelets modulate the immune response following trauma by interaction with CD4+ T regulatory cells in a mouse model. Immunol Res 64:508–517

Article  CAS  PubMed  Google Scholar 

Gerdes N, Zhu L, Ersoy M et al (2011) Platelets regulate CD4(+) T-cell differentiation via multiple chemokines in humans. Thromb Haemost 106:353–362

Article  CAS  PubMed  Google Scholar 

Akinosoglou K, Alexopoulos D (2014) Use of antiplatelet agents in sepsis: a glimpse into the future. Thromb Res 133:131–138

Article  CAS  PubMed  Google Scholar 

de Souza AWS, Machado NP, Pereira VM et al (2010) Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis. Circ J 74:1236–1241

Article  PubMed  Google Scholar 

Ueno M (2010) Antiplatelet therapy in the treatment of Takayasu arteritis. Circ J 74:1079–1080

Article  PubMed  Google Scholar